A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage
Clinical trial NCT01661140 · TERMINATED
Trial details
- NCT number
- NCT01661140
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2015-02-01
- Enrollment
- 427
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.